Side-by-side comparison of AI visibility scores, market position, and capabilities
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
NASDAQ-listed (AAPL) world's most valuable company at $391B revenue with iPhone, Mac, and $25B+ App Store; Apple Intelligence AI and Vision Pro spatial computing competing across smartphones, PC, wearables, and services.
Apple Inc. is a Cupertino, California-based technology company — listed on NASDAQ (NASDAQ: AAPL) and the world's most valuable company by market capitalization at $3+ trillion — designing and manufacturing consumer electronics (iPhone, Mac, iPad, Apple Watch, AirPods, Apple Vision Pro), operating system software (iOS, macOS, watchOS, visionOS), and digital services (App Store, Apple Music, iCloud, Apple TV+, Apple Pay, Apple Arcade) through a vertically integrated hardware-software-services model that generates unparalleled ecosystem lock-in and customer loyalty. Founded by Steve Jobs, Steve Wozniak, and Ronald Wayne in 1976, Apple generated $391 billion in revenue in fiscal year 2024 with 66% iPhone contribution.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.